參考文獻 |
Ai T, Fujiwara Y, Tsuji K, Otani H, Nakono S, Kubo Y, and Horie M.Novel KCJN2 mutation in familial periodic paralysis with ventriculardysrhythmia. Circulation 105: 2592–2594, 2002.
Andelfinger G, Tapper AR, Welch RC, Vanoye CG, George AL Jr,and Benson DW. KCJN2 mutation results in Andersen syndrome withsex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet 71:663–668, 2002.
Ruey J. Sung,1,2 Sheng-Nan Wu,3,4 Jiun-Shian Wu,3 Han-Dong Chang,3 and Ching-Hsing Luo5Electrophysiological mechanisms of ventricular arrhythmias in relation toAndersen-Tawil syndrome under conditions of reduced IK1: a simulation studyAm J Physiol Heart Circ Physiol 291: H2597–H2605, 2006
Ruey J. Sung,1,6 Yung-Han Wu,2 Nathan Hsing-Jung Lai,2 Chun-Hao Teng,3 Ching-Hsing Luo,4Hui-Chun Tien,5 Chu-Pin Lo,5 and Sheng-Nan Wu2 beta-Adrenergic modulation of arrhythmogenesis and identification of targetedsites of antiarrhythmic therapy in Timothy (LQT8) syndrome: a theoretical studyAm J Physiol Heart Circ Physiol 298: H33–H44, 2010
Gunnar Seemann,1 Frank B. Sachse,2,3 Daniel L. Weiss,1 Louis J. Pta´cˇek,4 and Martin Tristani-Firouzi2,5Modeling of IK1 mutations in human left ventricular myocytes and tissueAm J Physiol Heart Circ Physiol 292: H549–H559, 2007.
Gregory M. Faber,* Jonathan Silva,y Leonid Livshitz,y and Yoram RudyKinetic Properties of the Cardiac L-Type Ca21 Channel and Its Role inMyocyte Electrophysiology: A Theoretical Investigation Biophysical Journal Volume 92 March 2007 1522–1543
Li Zhang, MD; D. Woodrow Benson, MD, PhD; Martin Tristani-Firouzi, MD; Louis J. Ptacek, MD; Electrocardiographic Features in Andersen-Tawil SyndromePatients With KCNJ2 MutationsCharacteristic T-U–Wave Patterns Predict the KCNJ2 Genotype Circulation 2005;111;2720-2726; originally published online May 23, 2005
Julien Piron1–3, Khai Le Quang1–3, Francois Briec1–3, Jean-Christophe Amirault1,3,4, Anne-Laure Leoni1,3 Biological Pacemaker Engineered by NonviralGene Transfer in a Mouse Model of CompleteAtrioventricular Block Molecular Therapy vol. 16 no. 12, 1937–1943 dec. 2008
Sansone V, Griggs RC, Meola G, Ptacek LJ, Barohn R, Innaccone S,Bryan W, Baker N, Janas SJ, Scott W, Ririe D, and Tawil R.Andersen’s syndrome: a distinct periodic paralysis. Ann Neurol 42: 305–312, 1997.
Shimizu W and Antzelevitch C. Cellular basis for the electrocardiographic features of the LQT1 form of the long QT syndrome: effects of _-adrenergic agonists, antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 98: 2314–2322, 1998.
Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone V, Meola G, Hahn A, Bendahhou S, Kwiecinski H, Fidzianska A, Plaster N, Fu YH, Ptacek LJ, and Tawil R. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 11: 381–388, 2002.
Zoble C, Cho HC, Nguyen TT, Pekhletski R, Diaz RJ, Wilson GJ, and Backx PH. Molecular dissection of the inward rectifier potassium current (IK1) in rabbit cardiomyocytes: evidence for heteromeric co-assembly of Kir2.1 and Kir22. J Physiol 550: 365–372, 2003.
Luo CH and Rudy Y. A dynamic model of the cardiac ventricular action potential. I. Simulations of ionic currents and concentration changes. Circ Res 74: 1071–1096, 1994.
Kannankeril PJ, Roden DM, and Fish FA. Suppression of bidirectional ventricular tachycardia and unmasking of prolong QT interval with verapamil in Andersen’s syndrome. J Cardiovasc Electrophysiol 15: 119, 2004.
Tawil, R., et al Andersen’s syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann. Neurol. 35:326–330. 1994.
|